Neuroprotection may be implemented as an adjunct to recanalization therapies to provide patients with acute ischemic stroke with better clinical outcomes.
Does neuroprotection as an adjunct to recanalization therapies improve clinical outcomes in patients with acute ischemic stroke?
Neuroprotection strategies may serve as valuable adjuncts to recanalization therapies to further improve clinical outcomes in acute ischemic stroke.
2]3 At present, recanalization of the blocked cerebral arteries is the mainstay of emergency treatment.However, despite advances in recanalization, there remains an unmet need for outcomes from AIS to be improved further.Here, we discuss how this need may be addressed by neuroprotection, a treatment intended to slow stroke progression.Rather than focus on specific treatments or molecular targets, a topic of other prior reviews, 4-6 this contribution focuses on how neuroprotection may be implemented as an adjunct to recanalization therapies, to provide patients with AIS with better clinical outcomes.
Michael Tymianski (Wed,) conducted a review in Acute Ischemic Stroke (AIS). Neuroprotection was evaluated. Neuroprotection may be implemented as an adjunct to recanalization therapies to provide patients with acute ischemic stroke with better clinical outcomes.